Deutsche Bank
KBIO

Deutsche Bank’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Deutsche Bank’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,468
Closed -$84K – 5641
2015
Q4 		$84K Buy
+5,468
New +$60.5K ﹤0.01% 4150
2015
Q3 		– Sell
-1,872
Closed -$7K – 5648
2015
Q2 		$7K Buy
1,872
+509
+37% +$2.16K ﹤0.01% 5119
2015
Q1 		$5K Sell
1,363
-9,916
-88% -$44.5K ﹤0.01% 4914
2014
Q4 		$155K Buy
11,279
+6,329
+128% +$90.3K ﹤0.01% 4440
2014
Q3 		$60K Sell
4,950
-12,585
-72% -$174K ﹤0.01% 4768
2014
Q2 		$318K Buy
17,535
+659
+4% +$11.3K ﹤0.01% 3811
2014
Q1 		$365K Sell
16,876
-4,671
-22% -$135K ﹤0.01% 3529
2013
Q4 		$760K Sell
21,547
-1,765
-8% -$59.1K ﹤0.01% 2818
2013
Q3 		$841K Buy
23,312
+22,314
+2,236% +$1.02M ﹤0.01% 3109
2013
Q2 		$44K Buy
+998
New +$45.3K ﹤0.01% 4563

Other funds holding KBIO

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Deutsche Bank's KBIO Position: Q1 2016 in Review

Deutsche Bank sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 5,468 shares — an estimated $84K sold.

Deutsche Bank first reported a position in KBIO in Q2 2013 and held it in 10 quarters. The position peaked at $841K in Q3 2013. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

  • Deutsche Bank reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
  • Deutsche Bank sold 5,468 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016, an estimated $84K.
  • Deutsche Bank first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 10 quarters.
  • Deutsche Bank's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $841K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Deutsche Bank's 13F filing for Q1 2016, filed 16 May 2016.